India, April 8 -- KLEF Deemed to be University takes pride in announcing a notable breakthrough in the fight against Glioblastoma Multiforme (GBM), an aggressive and fatal form of brain cancer. Ms. Sahiti Chamarthy, a biotechnology research scholar at KLEF Deemed to be University, has made a pioneering discovery that could potentially contribute to brain cancer treatment.

GBM has long posed a significant challenge to the medical community, with patients typically surviving only 13 to 15 months post-diagnosis. Under the expert guidance of Dr. M. Janaki Ramayya, Professor of Biotechnology at KLEF Deemed to be University, Ms. Sahiti's research offers a new ray of hope through a novel dual-drug therapy.

Her research focuses on simultaneousl...